Evidence map›Paper›PMID 35128168›Full record

ArticleAmerican journal of ophthalmology case reports2022

An unusual presentation of peripapillary pachychoroid syndrome.

Sasha Hubschman, Kirk Hou, David Sarraf, Irena Tsui

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of ophthalmology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Pachychoroid disease: review and update.Eye (London, England) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Peripapillary pachychoroid syndrome successfully treated with topical prednisolone acetate 1% drops.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
  7. Pachychoroid Spectrum Disorders: An Updated Review.Journal of ophthalmic & vision research
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sasha HubschmanJules Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza Driveway, Los Angeles, CA, 90095, USA.
Kirk HouJules Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza Driveway, Los Angeles, CA, 90095, USA.
David SarrafJules Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza Driveway, Los Angeles, CA, 90095, USA.
Irena TsuiJules Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza Driveway, Los Angeles, CA, 90095, USA.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePeripapillary pachychoroid syndrome (PPS) is a recently described entity of the pachychoroid disease spectrum and is characterized by thickening of the nasal choroid and peripapillary fluid pockets. This case illustrates the remarkable natural history of this recently described disorder. OBSERVATION: This case report describes a patient with PPS who presented with severe cystoid macular edema (CME) that spontaneously resolved without treatment. CONCLUSIONS AND IMPORTANCE: This report indicates that PPS can exhibit significant fluctuation of CME and a favorable natural history in some cases. It also suggests that observation may be a viable option in the initial management of this finding if vision is not significantly unaffected.

Indexed as

Macular edemaPachychoroid disease spectrumPeripapillary pachychoroid syndrome

Identifiers

PMID35128168
PMCPMC8810369
OpenAlexW4206908149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.